Published in Crit Care on March 18, 2010
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care (2013) 0.99
A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial. Crit Care (2013) 0.88
Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit. Crit Care (2014) 0.83
Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis. Crit Care (2015) 0.78
Bioactivity of enoxaparin in critically ill patients with normal renal function. Br J Clin Pharmacol (2012) 0.76
Antifactor Xa levels in critically ill Korean patients receiving enoxaparin for thromboprophylaxis: a prospective observational study. J Korean Med Sci (2013) 0.75
Minimising drug errors in critically ill patients. Crit Care (2011) 0.75
Renal function and thromboprophylaxis in critically ill patients. Crit Care (2010) 0.75
Adequate thromboprophylaxis in critically ill patients. Crit Care (2010) 0.75
Does Obesity Predispose Medical Intensive Care Unit Patients to Venous Thromboembolism despite Prophylaxis? A Retrospective Chart Review. Crit Care Res Pract (2016) 0.75
Thrombosis prophylaxis in critically ill patients. Wien Med Wochenschr (2011) 0.75
Bemiparin versus Enoxaparin in the Prevention of Venous Thromboembolism among Intensive Care Unit Patients. Indian J Crit Care Med (2017) 0.75
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med (2006) 2.40
Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 2.19
Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med (2005) 1.87
Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill? Crit Care Med (2003) 1.87
Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med (2001) 1.68
Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet (2002) 1.32
Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin. Thromb Res (2002) 1.27
Prevention of venous thromboembolism in the ICU. Chest (2003) 1.24
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thromb Haemost (1989) 1.22
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Crit Care (2006) 1.22
Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg (1997) 1.11
Deep venous thrombosis: clinically silent in the intensive care unit. J Crit Care (2005) 1.08
Dosing and monitoring of low-molecular-weight heparins in special populations. Pharmacotherapy (2001) 1.03
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev (2000) 1.01
Preventing venous thromboembolism in medical patients. Circulation (2004) 1.01
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. J Crit Care (2005) 0.98
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors. Crit Care (2008) 0.96
Anticoagulation therapy. Hematology Am Soc Hematol Educ Program (2001) 0.91
The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapies. J Clin Pharmacol (2006) 0.85
Diagnostic significance of thrombin-antithrombin III complex (TAT) and D-dimer in patients with deep venous thrombosis. Jpn Circ J (1996) 0.79
Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent. Br J Haematol (1992) 0.78
A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet (2010) 5.84
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol (2012) 3.55
[In Process Citation]. Ugeskr Laeger (2015) 2.01
Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study. Chest (2015) 1.43
Aortic aneurysm disease vs. aortic occlusive disease: differences in outcome and intensive care resource utilisation after elective surgery: an observational study. Eur J Anaesthesiol (2013) 1.41
Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med (2004) 1.38
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis. BMJ (2012) 1.33
Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med (2013) 1.16
Long-term psychological effects of a no-sedation protocol in critically ill patients. Crit Care (2011) 1.09
Pathophysiology of the systemic inflammatory response after major accidental trauma. Scand J Trauma Resusc Emerg Med (2009) 1.08
Severe scurvy after gastric bypass surgery and a poor postoperative diet. J Clin Med Res (2012) 0.99
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy. Thromb Haemost (2015) 0.94
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis. Thromb Haemost (2014) 0.94
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. Clin Res Cardiol (2014) 0.92
Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand. BMJ Open (2012) 0.90
A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial. Crit Care (2013) 0.88
Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. BMJ Open (2012) 0.87
Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med (2013) 0.87
Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis. Stroke (2013) 0.87
Effect of targeted strength, endurance, and coordination exercise on neck and shoulder pain among fighter pilots: a randomized-controlled trial. Clin J Pain (2013) 0.85
Diagnosis and management of patients with inherited arrhythmia syndromes in Europe: results of the European Heart Rhythm Association Survey. Europace (2014) 0.83
Sedation and renal impairment in critically ill patients: a post hoc analysis of a randomized trial. Crit Care (2011) 0.83
Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. Europace (2014) 0.82
Reply: To PMID 22575324. J Am Coll Cardiol (2012) 0.81
[Sexual knowledge, attitudes and behavior among young Danes. A questionnaire study]. Ugeskr Laeger (2002) 0.80
Influence of endotoxin-induced sepsis on the requirements of propofol-fentanyl infusion rate in pigs. Basic Clin Pharmacol Toxicol (2007) 0.80
Neck pain among fighter pilots after the introduction of the JHMCS helmet and NVG in their environment. Aviat Space Environ Med (2011) 0.78
Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation. Thromb Haemost (2012) 0.78
The inflammatory response in blood and in remote organs following acute kidney injury. APMIS (2013) 0.78
Combined use of clinical pre-test probability and D-dimer test in the diagnosis of preoperative deep venous thrombosis in colorectal cancer patients. Thromb Haemost (2008) 0.78
Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics. Curr Opin Cardiol (2015) 0.77
Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex). J Am Coll Cardiol (2015) 0.77
The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study. Chest (2014) 0.77
Alcohol intake and prognosis of atrial fibrillation. Heart (2013) 0.77
More complications in patients with septic shock treated with dextran compared with crystalloids. Dan Med J (2015) 0.77
Age dependence of risk factors for stroke and death in young patients with atrial fibrillation: a nationwide study. Stroke (2014) 0.76
Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study. Thromb Haemost (2014) 0.76
Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report. Acta Derm Venereol (2012) 0.76
Comparison between cerebral tissue oxygen tension and energy metabolism in experimental subdural hematoma. Neurocrit Care (2011) 0.76
Left atrial size and risk of stroke in patients in sinus rhythm. A systematic review. Thromb Haemost (2016) 0.75
Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials. J Am Coll Cardiol (2013) 0.75
Using the CHA2DS2-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application. Can J Cardiol (2015) 0.75
Letter by christensen et Al regarding article, "new oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation". Circulation (2012) 0.75
A feasible strategy for preventing blood clots in critically ill patients with acute kidney injury (FBI): study protocol for a randomized controlled trial. Trials (2014) 0.75
An Official American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults. Rehabilitation Protocols, Ventilator Liberation Protocols, and Cuff Leak Tests. Am J Respir Crit Care Med (2016) 0.75
Data mining to assess variations in oral anticoagulant treatment. Stud Health Technol Inform (2010) 0.75
[Evidence-based pharmacological interventions in intensive therapy]. Ugeskr Laeger (2009) 0.75
Centrifuge-induced neck and back pain in F-16 pilots: a report of four cases. Aviat Space Environ Med (2013) 0.75
807: MELATONIN SECRETION PATTERN IN CRITICALLY ILL PATIENTS. Crit Care Med (2016) 0.75
[Acute renal failure in intensive care units--evidence and cost-benefit analysis when choosing the method of dialysis 1]. Ugeskr Laeger (2003) 0.75
Influence of Patients' "Sense of Coherence" on Main Postoperative Variables in the Postanesthesia Care Unit: A Cross-Sectional Study. AANA J (2015) 0.75
[Statins can maybe reduce the risk of venous thromboembolism]. Ugeskr Laeger (2011) 0.75
The immune response is affected for at least three weeks after extensive surgery for ovarian cancer. Dan Med J (2016) 0.75
Official Executive Summary of an American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults. Am J Respir Crit Care Med (2016) 0.75
[Cricoid pressure in rapid sequence intubation]. Ugeskr Laeger (2007) 0.75
1211: NO SEDATION FOR CRITICALLY ILL PATIENTS UNDERGOING MECHANICAL VENTILATION: A MULTICENTER TRIAL. Crit Care Med (2016) 0.75
[Delirium in the critically ill]. Ugeskr Laeger (2009) 0.75
Continuous renal replacement therapy for critically ill infants and children. Dan Med J (2012) 0.75
Self-testing and self-management of oral anticoagulation therapy in children. Thromb Haemost (2011) 0.75
White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction. Cerebrovasc Dis (2016) 0.75
[Diagnostics: new methodological initiatives]. Ugeskr Laeger (2004) 0.75
Monitoring of anticoagulant therapy applying a dynamic statistical model. Comput Methods Programs Biomed (2013) 0.75
[Loop diuretics improves diuresis, but not renal function in the intensive care patient with acute renal failure]. Ugeskr Laeger (2012) 0.75
Effect of renal and non-renal ischemia/reperfusion on cell-mediated immunity in organs and plasma. APMIS (2010) 0.75
[From recovery room to observation and therapeutic department]. Ugeskr Laeger (2004) 0.75
[Blood transfusion to non-bleeding, critically ill patients]. Ugeskr Laeger (2011) 0.75
Severe arterial thrombosis in a family with type III protein S deficiency caused by a frameshift mutation in the PROS1 gene. Thromb Res (2010) 0.75
[The Danish clinical guidelines (Klaringsrapporter, 1996-2001: Insufficient evidence presented for the diagnostic accuracy of recommended clinical-biochemical tests]. Ugeskr Laeger (2004) 0.75
Denaturing high-performance liquid chromatography mutation analysis in patients with reduced Protein S levels. Clin Chim Acta (2008) 0.75
[Fewer indications for sedation in mechanical ventilation therapy]. Ugeskr Laeger (2012) 0.75
Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke. Cerebrovasc Dis (2016) 0.75
Patients' perception of noise in the operating room--a descriptive and analytic cross-sectional study. J Perianesth Nurs (2014) 0.75
[Critical care research]. Ugeskr Laeger (2007) 0.75
Postural control and shoulder steadiness in F-16 pilots: a randomized controlled study. Aviat Space Environ Med (2014) 0.75
[Increased focus on the cerebrum in intensive care patients]. Ugeskr Laeger (2013) 0.75
More studies on outcomes using biochemical diagnostic tests are needed: findings from the Danish Society of Clinical Biochemistry. Clin Chem (2008) 0.75
[Intensive care--beneficial?]. Ugeskr Laeger (2007) 0.75
Adolescents' and Young Adults' Lived Experiences Following Venous Thromboembolism: "It will always lie in wait". Nurs Res (2016) 0.75